English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Summary A new approach has been developed to detect myocardial cell-hypertrophy, by measuring the intra-cellular lifetime of water in a mouse model of hypertensive heart disease, and validating the MRI marker against measurements of cell dimensions on stained heart slices. Background Cardiomyocyte hypertrophy occurs in cardiomyopathies and in response to pressure overload. However, only endomyocardial biopsies allow detection, with the inherent risks of invasive catheter-based procedures. Noninvasive detection of cardiomyocyte hypertrophy using imaging may detect disease at a subclinical stage and potentially guide therapy. To-date, no imaging-technique has been validated to detect hypertrophic response at the cellular level. We developed a novel measure of cell size based on the MRI determination of the intra-cellular lifetime (τic) of water, using pre/post-contrast T1 measurements and a 2-site H-exchange model (2SXmodel). We hypothesized that τic correlates positively with the histological measure of cardiomyocyte volume (Vic) in a rodent model of hypertensive heart disease. Methods L-NAME (3mg/ml) or placebo were administered respectively to 17 (bw=37.2±2.3g) and 13 (bw=37.5 ±2.5g) male-wild-type mice. Mice were imaged at baseline and 7-weeks after treatment on a 4.7T-small-animal MRI-system. T1 (>5T1 measurement/mouse) was quantified with a modified Look-Locker gradient-echo-cine technique, before and after fractionated GadoliniumDPTA administration. Minor (Dmin) and major (Dmaj) cell-diameters were measured by FITC-labeled wheat germ-agglutinin staining of cell membranes. Morphometric analysis was performed with a computer-based system. Vic was calculated from Dmin and Dmaj celldiameters using a cylindrical cell-shape approximation. Results L-NAME-treated-mice developed hypertrophy (weightindexed LVMass 4.1±0.4 for L-NAME vs. 2.2±0.3μg/g for placebo, p<0.001). Vic (from histology) was substantially higher in L-NAME-treated-animals (19.4*10 3 ,I QR 917.1*10 3 μmm 3 vs. 10.7*10 3 , IQR 9.3*10 3 μmm 3 ; p<0.0001), while Dmaj/Dmin was smaller (3.4 vs. 4.2, p<1e-7), compared to controls. τic was significantly higher in L-NAME-treated animals (0.453±0.10 vs. 0.234 ±0.06, p<0.0001). τic increased significantly from baseline to 7-weeks in animals treated with L-NAME (p<0.0001) (Figure 1). τic strongly correlated with the minor cell diameter (r=0756, P<0.001), Vic (r=0.875, r<0.001) (Figure 1), and more weakly with the major cell-diameter (r=0.478, p=0.02). τic also correlated with weight-indexed LVMass (r=0.71, p<0.001). τic demonstrated an increase from baseline to 7-week (0.177 ±0.15), which follows the increase of LVmass (39.43 ±36.6μg/g) in the same interval (r=0.69, p<0.001).

MRI based non-invasive detection of cardiomyocyte hypertrophy and cell-volume changes